The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo

Stem Cell Research and Therapy

Volumn 7, Issue 1, 2016, Pages

  Hu, Shuling ^a   Li, Jinze ^a   Xu, Xiuping ^a   Liu, Airan ^a   He, Hongli ^a   Xu, Jingyuan ^a   Chen, Qihong ^a   Liu, Songqiao ^a   Liu, Ling ^a   Qiu, Haibo ^a   Yang, Yi ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Acute lung injury; Hepatic growth factor; Lung vascular permeability; Mesenchymal stem cell

Indexed keywords

CYTOKINE; EVANS BLUE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LENTIVIRUS VECTOR; MESSENGER RNA; SCATTER FACTOR; VASCULAR ENDOTHELIAL CADHERIN; CADHERIN; CDH1 PROTEIN, RAT; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA;

ADHERENS JUNCTION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG ALVEOLUS CELL; LUNG BLOOD VESSEL; LUNG WET WEIGHT TO BODY WEIGHT RATIO; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT PARAMETERS; TUNEL ASSAY; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; BODY WEIGHT; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LENTIVIRINAE; LUNG; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; REPORTER GENE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BODY WEIGHT; CADHERINS; CAPILLARY PERMEABILITY; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; LENTIVIRUS; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 85007297154     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-016-0320-5     Document Type: Article

References (35)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685-93. doi:10.1056/NEJMoa050333.
2. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-8. doi:10.1056/NEJM200005043421801.
3. Buregeya E, Fowler RA, Talmor DS, Twagirumugabe T, Kiviri W, Riviello ED. Acute respiratory distress syndrome in the global context. Glob Heart. 2014;9(3):289-95. doi:10.1016/j.gheart.2014.08.003.
4. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012;122(8):2731-40. doi:10.1172/JCI60331.
5. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009;106(38):16357-62. doi:10.1073/pnas.0907996106.
6. Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187(7):751-60. doi:10.1164/rccm.201206-0990OC.
7. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med. 2010;38(10 Suppl):S569-73. doi:10.1097/CCM.0b013e3181f1ff1d.
8. Liang X, Ding Y, Zhang Y, Tse HF, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23(9):1045-59. doi:10.3727/096368913X667709.
9. Matthay MA. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Ann Am Thorac Soc. 2015;12 Suppl 1:S54-7. doi:10.1513/AnnalsATS.201406-254MG.
10. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008;294(3):C675-82. doi:10.1152/ajpcell.00437.2007.
11. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11(4):367-8. doi:10.1038/nm0405-367.
12. Chen QH, Liu AR, Qiu HB, Yang Y. Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem Cell Res Ther. 2015;6(1):44. doi:10. 1186/s13287-015-0025-1.
13. Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 2002;9(17):1155-62. doi:10.1038/sj.gt.3301731.
14. Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, et al. Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 2013;228(6):1270-83. doi:10.1002/jcp. 24282.
15. He H, Liu L, Chen Q, Liu A, Cai S, Yang Y, et al. Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharideinduced lung injury. Cell Transplant. 2015;24(9):1699-1715. doi:10.3727/096368914X685087.
16. Adachi E, Hirose-Sugiura T, Kato Y, Ikebuchi F, Yamashita A, Abe T, et al. Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury. Pharmacology. 2014;94(3-4):190-7. doi:10.1159/000363412.
17. Meng F, Meliton A, Moldobaeva N, Mutlu G, Kawasaki Y, Akiyama T, et al. Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2015;308(5):L452-63. doi:10.1152/ajplung.00170.2014.
18. Wang X, Li Q, Hu Q, Suntharalingam P, From AH, Zhang J. Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31-cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration. Plos One. 2014;9(2):e95247. doi:10.1371/journal.pone.0095247.
19. Li J, Zheng CQ, Li Y, Yang C, Lin H, Duan HG. Hepatocyte growth factor gene-modified mesenchymal stem cells augment sinonasal wound healing. Stem Cells Dev. 2015;24(15):1817-1830. doi:10.1089/scd.2014.0521.
20. Seo KW, Sohn SY, Bhang DH, Nam MJ, Lee HW, Youn HY. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats. Cell Biol Int. 2014;38(1):106-16. doi:10.1002/cbin. 10186.
21. Kim MD, Kim SS, Cha HY, Jang SH, Chang DY, Kim W, et al. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Exp Mol Med. 2014;46:e110. doi:10.1038/emm.2014.49.
22. Awada HK, Johnson NR, Wang Y. Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects. Macromol Biosci. 2014;14(5):679-86. doi:10.1002/mabi. 201300486.
23. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, et al. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology. 2014;59(5):1874-85. doi:10.1002/hep. 26941.
24. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G. HGF receptor upregulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood. 2003;101(12):4816-22. doi: 10.1182/blood-2002-06-1731.
25. Yu F, Lin Y, Zhan T, Chen L, Guo S. HGF expression induced by HIF-1alpha promote the proliferation and tube formation of endothelial progenitor cells. Cell Biol Int. 2015;39(3):310-7. doi:10.1002/cbin. 10397.
26. Panganiban RA, Day RM. Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacol Sin. 2011;32(1):12-20. doi:10.1038/aps.2010.90.
27. Gazdhar A, Fachinger P, van Leer C, Pierog J, Gugger M, Friis R, et al. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycininduced lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2007;292(2):L529-36. doi:10.1152/ajplung.00082.2006.
28. Higginbotham K, Tian Y, Gawlak G, Moldobaeva N, Shah A, Birukova AA. Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement. Cell Signal. 2014;26(11):2306-16. doi:10.1016/j.cellsig.2014.07.032.
29. Martin TA, Mansel RE, Jiang WG. Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol. 2002;192(3):268-75. doi:10.1002/jcp. 10133.
30. Gazdhar A, Grad I, Tamo L, Gugger M, Feki A, Geiser T. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther. 2014;5(6):123. doi:10.1186/scrt513.
31. Chakraborty S, Chopra P, Hak A, Dastidar SG, Ray A. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis. Expert Opin Investig Drugs. 2013;22(4):499-515. doi:10.1517/13543784.2013.778972.
32. Molnarfi N, Benkhoucha M, Funakoshi H, Nakamura T, Lalive PH. Hepatocyte growth factor: a regulator of inflammation and autoimmunity. Autoimmun Rev. 2015;14(4):293-303. doi:10.1016/j.autrev. 2014.11.013.
33. Wang H, Sun RT, Li Y, Yang YF, Xiao FJ, Zhang YK, et al. HGF gene modification in mesenchymal stem cells reduces radiation-induced intestinal injury by modulating immunity. Plos One. 2015;10(5):e124420. doi: 10.1371/journal.pone.0124420.
34. Loghmanpour NA, Druzdzel MJ, Antaki JF. Cardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy. Plos One. 2014;9(11):e111264. doi:10.1371/journal.pone.0111264.
35. Zhang J, Zhou S, Zhou Y, Feng F, Wang Q, Zhu X, et al. Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. Plos One. 2014;9(12):e114670. doi:10.1371/journal.pone.0114670.